Cognitive-motor Training for PD
Trial
N/A
Unknown
Jan. 17, 2022
Effect of Bright Light on Mood and Sleep in Parkinson's Disease
Trial
N/A
Completed
Jan. 10, 2022
Auricular Muscle Zone Stimulation for Parkinson Disease
Trial
Phase 2
Completed
Jan. 10, 2022
18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety
Trial
Phase 3
Completed
Jan. 9, 2022
BUrst vs. Spaced Physical Therapy for Parkinson's Disease: The BUS PT Timing Trial
Trial
N/A
Completed
Jan. 5, 2022
Effect of Ketone Esters in Parkinson's Disease
Trial
N/A
Completed
Jan. 3, 2022
Attending to External Cues and Movement Strategies in Parkinson Disease
Trial
N/A
Completed
Jan. 3, 2022
Study on the Safety, Tolerance and Pharmacokinetics of Phenlarmide Tablets
Trial
Phase 1
Completed
Jan. 2, 2022
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease
Trial
Phase 1
Unknown
Dec. 29, 2021
A Training of the Rhythmic Skills With a Serious Game to Improve Gait and Cognitive Abilities in Parkinson's Disease
Trial
N/A
Suspended
Dec. 28, 2021
Proof of Concept BeatPark
Trial
N/A
Terminated
Dec. 28, 2021
In Vivo Alzheimer Proteomics
Trial
N/A
Terminated
Dec. 27, 2021
Assisted Device for Freezing in Parkinson Disease
Trial
N/A
Terminated
Dec. 27, 2021
Gait and REM Sleep Behavior Disorder
Trial
N/A
Terminated
Dec. 22, 2021
Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD)
Trial
N/A
Completed
Dec. 21, 2021
The Effect of Repetitive Transcranial Magnetic Stimulation on Cognitive Impairment in Parkinson's Disease (PD)
Trial
N/A
Completed
Dec. 20, 2021
Evaluation of Using Vibrotactile Coordinated Reset for Management of Parkinson's Disease
Trial
N/A
Terminated
Dec. 20, 2021
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
Trial
N/A
Completed
Dec. 14, 2021
A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease
Trial
Phase 1
Withdrawn
Dec. 14, 2021
A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China
Trial
Phase 1
Completed
Dec. 13, 2021